Source: Circulation-cardiovascular interventions. Unidade: FM
Subjects: PLAQUETAS SANGUÍNEAS, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, HEMORRAGIA, NEOPLASIAS
ABNT
CAMPOS, Carlos M et al. Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials. Circulation-cardiovascular interventions, v. 17, n. 4, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76797. Acesso em: 08 nov. 2025.APA
Campos, C. M., Mehran, R., Capodanno, D., Owen, R., Windecker, S., Varenne, O., et al. (2024). Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials. Circulation-cardiovascular interventions, 17( 4). doi:10.1161/CIRCINTERVENTIONS.122.013000NLM
Campos CM, Mehran R, Capodanno D, Owen R, Windecker S, Varenne O, Stone GW, Valgimigli M, Hajjar LA, Kalil Filho R. Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials [Internet]. Circulation-cardiovascular interventions. 2024 ; 17( 4):[citado 2025 nov. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76797Vancouver
Campos CM, Mehran R, Capodanno D, Owen R, Windecker S, Varenne O, Stone GW, Valgimigli M, Hajjar LA, Kalil Filho R. Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials [Internet]. Circulation-cardiovascular interventions. 2024 ; 17( 4):[citado 2025 nov. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76797
